Nisa Investment Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,953 shares of SUPN stock, worth $74,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,953

Previous 1,696 15.15%

Holding current value

$74,077

Previous $52,000 34.62%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$31.89 - $37.83 $8,195 - $9,722	257 Added 15.15%	1,953 $70,000
Q3 2024 Oct 24, 2024	BUY	$25.77 - $35.16 $1,185 - $1,617	46 Added 2.79%	1,696 $52,000
Q2 2024 Jul 19, 2024	SELL	$25.99 - $33.85 $10,084 - $13,133	-388 Reduced 19.04%	1,650 $44,000
Q1 2024 May 01, 2024	BUY	$27.11 - $35.17 $13,094 - $16,987	483 Added 31.06%	2,038 $69,000
Q4 2023 Jan 25, 2024	SELL	$22.72 - $29.68 $27,036 - $35,319	-1,190 Reduced 43.35%	1,555 $45,000
Q3 2023 Nov 02, 2023	SELL	$27.57 - $32.91 $275 - $329	-10 Reduced 0.36%	2,745 $75,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $17,347 - $22,463	-580 Reduced 17.39%	2,755 $82,000
Q1 2023 May 02, 2023	SELL	$34.93 - $42.03 $3,143 - $3,782	-90 Reduced 2.63%	3,335 $121,000
Q3 2022 Nov 07, 2022	BUY	$28.79 - $35.41 $1,007 - $1,239	35 Added 1.03%	3,425 $117,000
Q2 2022 Aug 03, 2022	BUY	$25.33 - $34.25 $18,997 - $25,687	750 Added 28.41%	3,390 $98,000
Q1 2022 Apr 29, 2022	SELL	$28.51 - $32.9 $114,125 - $131,698	-4,003 Reduced 60.26%	2,640 $85,000
Q4 2021 Feb 03, 2022	BUY	$26.37 - $34.22 $73,915 - $95,918	2,803 Added 72.99%	6,643 $205,000
Q3 2021 Oct 18, 2021	BUY	$23.54 - $31.39 $2,354 - $3,139	100 Added 2.67%	3,840 $102,000
Q2 2021 Aug 06, 2021	BUY	$26.72 - $33.19 $7,748 - $9,625	290 Added 8.41%	3,740 $115,000
Q4 2020 Jan 25, 2021	BUY	$17.7 - $25.81 $3,894 - $5,678	220 Added 6.81%	3,450 $87,000
Q3 2020 Oct 20, 2020	SELL	$20.2 - $25.05 $450,399 - $558,539	-22,297 Reduced 87.35%	3,230 $67,000
Q2 2020 Jul 27, 2020	BUY	$17.09 - $24.89 $399,222 - $581,430	23,360 Added 1077.99%	25,527 $606,000
Q1 2020 Apr 17, 2020	BUY	$14.45 - $24.69 $8,670 - $14,814	600 Added 38.29%	2,167 $39,000
Q4 2019 Jan 17, 2020	SELL	$19.93 - $29.13 $163,485 - $238,953	-8,203 Reduced 83.96%	1,567 $37,000
Q3 2019 Oct 17, 2019	BUY	$25.47 - $33.37 $15,103 - $19,788	593 Added 6.46%	9,770 $268,000
Q1 2019 Apr 17, 2019	BUY	$32.77 - $41.99 $290,243 - $371,905	8,857 Added 2767.81%	9,177 $322,000
Q1 2018 Apr 10, 2018	SELL	$37.15 - $46.9 $1,857 - $2,345	-50 Reduced 13.51%	320 $15,000
Q3 2017 Oct 13, 2017	BUY	$36.75 - $49.65 $13,597 - $18,370	370	370 $15,000

Others Institutions Holding SUPN

# of Institutions

296

Shares Held

61.1M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.03B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Supernus Pharmaceuticals, Inc. Transaction History